KURA
Kura Oncology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.65
-0.19 ▼ -2.15%
🌙 3월 13일 6:27 PM ET (한국 3/14 07:27)
$8.52
-0.13 ▼ -1.50%
| Index | RUT | P/E | - | EPS (ttm) | -3.18 | Insider Own | 3.07% | Shs Outstand | 0.09B | Perf Week | -3.46% |
| Market Cap | 0.76B | Forward P/E | - | EPS next Y | 26.5% | Insider Trans | -6.63% | Shs Float | 0.09B | Perf Month | 10.33% |
| Enterprise Value | 0.12B | PEG | - | EPS next Q | -0.81 | Inst Own | 96.43% | Short Float | 17.03% | Perf Quarter | -19.46% |
| Income | -0.28B | P/S | 11.32 | EPS this Y | -10.72% | Inst Trans | 0.96% | Short Ratio | 9.27 | Perf Half Y | -1.98% |
| Sales | 0.07B | P/B | 4.36 | EPS next 5Y | 23.15% | ROA | -31.33% | Short Interest | 14.58M | Perf YTD | -16.75% |
| Book/sh | 1.98 | P/C | 1.15 | EPS past 3/5Y | -16.16% -13.48% | ROE | -94.82% | 52W High | -30.74% ($12.49) | Perf Year | 18.82% |
| Cash/sh | 7.55 | P/FCF | - | Sales past 3/5Y | - | ROIC | -144.15% | 52W Low | 59.89% ($5.41) | Perf 3Y | -22.91% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -57.05% | Gross Margin | 98.39% | Volatility(W/M) | 5.69% 5.05% | Perf 5Y | -70.68% |
| Dividend TTM | - | EV/Sales | 1.74 | Sales Y/Y TTM | 25.24% | Oper. Margin | -449.94% | ATR (14) | 0.46 | Perf 10Y | 104.01% |
| Dividend Ex-Date | - | Quick Ratio | 6.05 | EPS Q/Q | -317.19% | Profit Margin | -412.95% | RSI (14) | 48.55 | Recom | 1.21 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.06 | Sales Q/Q | -67.83% | SMA20 | -0.32% ($8.68) | Beta | 0.21 | Target Price | $32.36 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 3000000 | SMA50 | -0.6% ($8.7) | Rel Volume | 0.82 | Prev Close | $8.84 |
| Employees | 260 | LT Debt/Eq | 0.11 | EPS/Sales Surpr. | -43.97% -51.07% | SMA200 | 2.07% ($8.47) | Avg Volume(3M) | 1.57M | Price | $8.65 |
| IPO | 2015/9/16 | Option/Short | Yes/Yes | Trades | 9136 | Volume | 1,285,241 | Change | -2.15% |
뉴스 로딩 중...